Search clinical trials for: Prasugrel 5mg

Total 12627 results

Elliot Israel, MD
Brigham and Women's Hospital

Completed

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) (Aspirin)

Asthma, Aspirin-Induced | Aspirin Exacerbated Asthma

United States
Lene Holmvang

Completed

Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI (TAILOR)

Coronary Artery Disease | Percutaneous Coronary Intervention | Acute Coronary Syndromes

Denmark
Assistance Publique - Hôpitaux de Paris
Eli Lilly and Company; Daiichi Sankyo, Inc.; Stentys; Accumetrics, Inc.; Allies in...

Completed

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel (ANTARCTIC)

Acute Coronary Syndrome

France
Università degli Studi di Ferrara

Completed

Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse (FABOLUS PRO)

ST Segment Elevation Myocardial Infarction

Italy
TWi Biotechnology, Inc.

Completed

Study of AC-201 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Taiwan
Daiichi Sankyo, Inc.
Eli Lilly and Company

Completed

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease (SWAP-2)

Coronary Artery Disease

United Kingdom, United States
University of Nebraska
Eli Lilly and Company; Daiichi Sankyo, Inc.

Completed

Platelet Inhibition in Patients With Systolic Heart Failure

Systolic Heart Failure

United States
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
Medical University of Vienna

Completed

The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation

Sepsis | Healthy Volunteers

Austria
Can-Fite BioPharma

Completed

Safety and Efficacy Study of CF101 to Treat Psoriasis

Plaque Psoriasis

Israel
Johns Hopkins University
Cultivate Biologics

Completed

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

Cannabis

United States
GlaxoSmithKline

Withdrawn

GSK2190915 Pediatric Study

Asthma
Meditrix Corp
National University of Ireland, Galway, Ireland; Boston Scientific Japan K.K.; Fujita Health University

Recruiting

Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study (ASET-JAPAN)

Chronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary Syndrome

Japan, Ireland
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Haisco Pharmaceutical Group Co., Ltd.

Completed

Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers

Healthy

China
Pedro A. Lemos
Imperial College London; Cardialysis B.V.

Unknown

Acetyl Salicylic Elimination Trial: The ASET Pilot Study (ASET)

Monotherapy After PCI

Brazil
Eli Lilly and Company
Daiichi Sankyo, Inc.; The TIMI Study Group

Completed

Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting (PRINCIPLE)

Coronary Artery Disease

France, United States, Israel, Germany
Tufts University

Completed

Microbiota Diversity and Composition and Polyphenol Bioavailability

Fecal Microbiota

United States
Seung Up Kim

Active, not recruiting

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Hepatitis B, Chronic | Fibrosis, Liver

Korea, Republic of
TaiwanJ Pharmaceuticals Co., Ltd

Terminated

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies (JKB122)

Chronic Hepatitis C

Taiwan
University of Patras

Completed

Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

Coronary Artery Disease | Acute Coronary Syndrome

Greece
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment

Coronary Artery Disease (CAD)

Greece
AORTICA Group

Completed

Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI (COMPARE)

ST Elevation Myocardial Infarction

Spain
Federal University of São Paulo

Completed

Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis (SAMPA)

Acute Coronary Syndrome | Platelet Function

Brazil
Deutsches Herzzentrum Muenchen

Unknown

Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing (ISAR ADAPT PF)

Coronary Heart Disease

Germany, Hungary
University of Patras

Completed

Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

Platelet Reactivity

Greece
University of Patras

Completed

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI) (PRO-GR-4)

Myocardial Infarction

Greece
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

Hemodialysis | Chronic Renal Failure

Greece
Eisai Co., Ltd.

Completed

A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015)

Healthy

Japan
Hotel Dieu de France Hospital

Unknown

Ticagrelor and Endothelial Function

Antiplatelet Agents; Endothelial Function; Pleotropic Effects

Lebanon
Careggi Hospital

Completed

Rapid Activity of Platelet Inhibitor Drugs Study (RAPID)

ST-segment Elevation Myocardial Infarction

Italy
University of Patras

Completed

Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study

Coronary Artery Disease | Acute Coronary Syndrome

Greece
University of Patras

Completed

Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease

Coronary Artery Disease | Endothelial Function

Greece
University of Patras

Completed

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Platelet Reactivity

Greece
Assistance Publique Hopitaux De Marseille

Completed

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

Acute Coronary Syndromes

France
Gennaro Sardella

Completed

Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial (RESET GENE)

Acute Coronary Syndrome

Italy
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Not yet recruiting

A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
University of Florida
Scott R. MacKenzie Foundation

Completed

Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI (SWAP-6)

Coronary Artery Disease | Acute Coronary Syndrome

United States
CirQuest Labs, LLC

Withdrawn

A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response

Diabetes Mellitus
University of Florida

Completed

Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes

Coronary Artery Disease | Diabetes Mellitus

United States
University of Florida

Completed

Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease

Coronary Artery Disease

United States
Royal Brompton & Harefield NHS Foundation Trust
University Hospital Tuebingen

Terminated

Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention (APACS-HPR)

Cardiovascular Disease | Acute Coronary Syndrome

Germany
Chiang Mai University

Unknown

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Antiplatelet Agents | Dental Diseases | Antiplatelet Drugs
University of Roma La Sapienza

Completed

High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients (TRIPLETE RESET)

Coronary Artery Disease

Italy
Eli Lilly and Company

Completed

Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

Acute Coronary Syndrome

India
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).

Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)

Greece
Indiana University

Terminated

Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Coronary Artery Disease | Thrombosis

United States
David Antoniucci
A.R. CARD Onlus Foundation

Completed

Rapid Activity of Platelet Inhibitor Drugs Study 2

Myocardial Infarction

Italy
Gennaro Sardella

Unknown

Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome (RESET ELDERLY)

Coronary Artery Disease

Italy
Amsterdam UMC, location VUmc
Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Unknown

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor (REDUCE-MVI)

Myocardial Infarction

Netherlands

3

Subscribe